Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Lowers Price Target to $343
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Benjamin Burnett maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Equal-Weight and lowers the price target from $362 to $343.
Wells Fargo analyst Benjamin Burnett maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Equal-Weight and lowers the price target from $362 to $343.